Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Second response from Hawk on Feb. licenses
Thanks. I appreciate your efforts. Considering PTSC has not considered the settlements "material", nor made us aware of what I consider to be material changes to the revenue structure, I have to "infer" (that word that Hawk likes so much lol), that there are no recurring revs or ongoing royalties. The absence of information, in this regard, IMO, provides the answers.
Share
New Message
Please login to post a reply